key: cord-0885343-rw8m2lad authors: Vaid, Akhil; Jaladanki, Suraj K; Xu, Jie; Teng, Shelly; Kumar, Arvind; Lee, Samuel; Somani, Sulaiman; Paranjpe, Ishan; De Freitas, Jessica K; Wanyan, Tingyi; Johnson, Kipp W; Bicak, Mesude; Klang, Eyal; Kwon, Young Joon; Costa, Anthony; Zhao, Shan; Miotto, Riccardo; Charney, Alexander W; Böttinger, Erwin; Fayad, Zahi A; Nadkarni, Girish N; Wang, Fei; Glicksberg, Benjamin S title: Federated Learning of Electronic Health Records Improves Mortality Prediction in Patients Hospitalized with COVID-19 date: 2020-08-14 journal: medRxiv DOI: 10.1101/2020.08.11.20172809 sha: f94b5eeaae35cc7f8f49a360fe4c4550dacb17ab doc_id: 885343 cord_uid: rw8m2lad Machine learning (ML) models require large datasets which may be siloed across different healthcare institutions. Using federated learning, a ML technique that avoids locally aggregating raw clinical data across multiple institutions, we predict mortality within seven days in hospitalized COVID-19 patients. Patient data was collected from Electronic Health Records (EHRs) from five hospitals within the Mount Sinai Health System (MSHS). Logistic Regression with L1 regularization (LASSO) and Multilayer Perceptron (MLP) models were trained using local data at each site, a pooled model with combined data from all five sites, and a federated model that only shared parameters with a central aggregator. Both the federated LASSO and federated MLP models performed better than their local model counterparts at four hospitals. The federated MLP model also outperformed the federated LASSO model at all hospitals. Federated learning shows promise in COVID-19 EHR data to develop robust predictive models without compromising patient privacy. Coronavirus disease 2019 has led to over 700,000 deaths worldwide and other devastating outcomes. [1] Clinical manifestations occur in heterogeneous patterns that are not yet well understood, creating an urgent need to understand factors that lead to negative outcomes to aid delivery of more tailored treatments. This task requires learning from large, diverse patient populations. However, pertinent patient data are siloed within hospitals worldwide. While many studies have produced significant findings in regards to COVID-19 outcomes using data from single hospitals, larger representation from additional populations is needed to derive generalizable outcomes, especially within the context of machine learning (ML). [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] Large-scale initiatives such as the National COVID Cohort Collaborative and the 4CE Consortium have joined globally distributed hospitals to examine association analyses, but meta-analysis does not allow joint machine learning from diverse patient data. [12] [13] In light of patient privacy, federated learning is emerging within the biomedical field as a promising strategy particularly in the context of COVID-19 where patient data are fragmented across health systems which are not representative of the entire population, leading to predictions that may not be generalizable. [14] Briefly, federated learning allows for decentralized refinement of independently built ML models. This is done via iterative exchange of model parameters to a central aggregator without sharing raw data. A limited number of studies have assessed ML models within a federated learning framework for outcome prediction in COVID-19 but show promise. Kumar et al. built a blockchain-based federated learning schema and achieved enhanced sensitivity for COVID-19 detection from lung CT scans. [15] Xu et al. used deep learning to identify COVID-19 on CT scans from multiple hospitals in China [16] and found that models built on hospitals in one region did not generalize . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted August 14, 2020. . https://doi.org/10.1101/2020.08.11.20172809 doi: medRxiv preprint well to others, but were able to achieve considerable performance gains when using a federated learning approach. For more detailed background regarding COVID-19, ML in the context of COVID-19, challenges for multi-institutional collaborations, and federated learning, see While it has been proposed, to our knowledge there are no published studies that implement and assess the utility of federated learning to predict COVID-19 outcomes from Electronic Health Record (EHR) data. [17] In this work, we are the first to build federated learning models to predict mortality in patients diagnosed with COVID-19 within seven days of hospital admission using EHR data. We performed multiple experiments as outlined in Figures 1B and 1C (see Model Development and Selection). First, we developed classifiers using and testing on local data from each hospital separately. We also built a federated learning model by averaging the parameters of models . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted August 14, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted August 14, 2020. Values with fewer than ten patients per field are not provided to protect patient privacy. To promote replicability, we placed our study within the Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD) guidelines (Supplementary . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted August 14, 2020. . https://doi.org/10.1101/2020.08.11.20172809 doi: medRxiv preprint The primary outcome was mortality within seven days of admission. We generated two baseline conventional predictive models -a multilayer perceptron (MLP) and logistic regression with L1-regularization, or least absolute shrinkage and selection operator Through this technique, federated models did not receive any raw data. All models were trained and evaluated using 10-fold stratified cross validation. We utilized the models' probability scores to calculate areas under the receiver operating characteristic curve (AUC-ROC) with averages across the 10 folds. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted August 14, 2020. . https://doi.org/10.1101/2020.08.11.20172809 doi: medRxiv preprint EHR data consisted of patient demographics, past medical history (Table 1) , and admission vitals and labs (Supplementary Table 1 ). We found significant differences across hospitals in the proportion of outcome, specifically mortality within seven days (p<0.001), which ranged from 5.6% to 24.2% (Table 1 ). There were also significant differences in gender (p=0.004), age (p<0.001), ethnicity (p<0.001), and race (p<0.001). We found significant differences in the majority of key clinical features such as past medical history like asthma (p<0.001) and relevant lab tests including white blood cell counts (p<0.001; Supplementary Table 1) . LASSO and MLP models trained on data from each of the five MSHS hospitals (sites) separately (local), combined dataset (pooled), and via a federated learning framework (federated). All three training strategies for both models were evaluated on all sites ( Figure 1B Supplementary Table 4 . Performance of all LASSO and MLP models (local, pooled, federated) was assessed at each site (Table 2, Figure 3 ). Federated LASSO outperformed the site's local LASSO at all sites except MSQ, with AUC-ROC ranging from 0.693 to 0.805. LASSO pooled outperformed federated LASSO at all five sites and had AUC-ROCs ranging from 0.736 to 0.822. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted August 14, 2020. . https://doi.org/10.1101/2020.08.11.20172809 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted August 14, 2020. . https://doi.org/10.1101/2020.08.11.20172809 doi: medRxiv preprint except MSB. Additional performance metrics (AUPRC, accuracy, sensitivity, specificity, and F1score) are described in Supplementary Table 5 . To our knowledge, this is the first study to evaluate the efficacy of applying federated learning to predict mortality for COVID-19 using clinical data from EHRs. The data from the five hospitals used in this study represent a demonstrative use-case for this experiment. With disparate patient characteristics per hospital in terms of demographics, outcomes, sample size, and lab values, this study reflects a real-world scenario where federated learning can be leveraged for hospitals with diverse patient populations. The primary findings of this study demonstrate that federated MLP and LASSO models outperformed their respective local models at most sites. Federated LASSO did not outperform pooled LASSO at any hospital. Federated MLP outperformed local MLP and federated LASSO at all hospitals. Federated MLP also outperformed pooled MLP at all sites which might be due to the experimental condition where the same underlying architecture was used for all MLP models. While this framework allowed for consistency in comparisons across learning strategies, it may have led to improper tuning of the pooled models. Collectively, these results exhibit the potential of federated learning to overcome drawbacks of fragmented local models. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted August 14, 2020. . https://doi.org/10.1101/2020.08.11.20172809 doi: medRxiv preprint Future inclusion of more sites into the federated learning network could continue to bridge the gap between pooled models, especially for LASSO. Our results illustrate scenarios in which federated models should either be approached with caution or favored. MSQ was the only hospital where federated LASSO performed slightly worse than the local model with a difference of 0.04 in AUC-ROC, which may be attributed to a low sample size of 540 patients and a high mortality prevalence of 23.0% compared to other sites. However, at MSW, local LASSO severely underperformed in comparison to federated LASSO, with a difference of 0.351. MSW had the lowest sample size of all hospitals at 485 and the lowest COVID-19 mortality prevalence of 5.6%. This pattern emphasizes the benefit of federated learning for sites with small sample sizes and large class imbalance. We also assessed the impact of adding noise to federated MLP. Training metrics were similar to federated MLP without noise insertion (Supplemental Figure 2 ). An average difference of 0.013 in AUC-ROC across all hospitals in these two models demonstrates that noise may be inserted to increase data security without severely compromising federated model performance. We note a few limitations of our study. First, data collection was limited to MSHS hospitals in NYC. This may limit model generalizability to hospitals in other regions. Also, this study focused on applying federated learning to predict outcomes based on patient EHR data in principle rather than creating an operational framework for immediate deployment. As such, there are various aspects of the federated learning process that this work does not address such as load balancing, convergence, and scaling. These models included only clinical data and could be enhanced by incorporating other modalities such as imaging or free-text. We only implemented two widely used classifiers within this framework, but other algorithms may perform better. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted August 14, 2020. . https://doi.org/10.1101/2020.08.11.20172809 doi: medRxiv preprint Finally, identical MLP architectures were used across all learning strategies for direct comparisons but could have been further optimized. Future work will focus on accessibility and expanding analysis of federated models. We plan to release code written within common data model EHR formats to better facilitate scalability. We will study salient features of importance for federated models and analyze changes as data are added. Finally, we will integrate additional data types such as images to improve model performance. We aim to use this federated learning framework to predict other adverse outcomes in hospitalized COVID-19 patients such as acute kidney injury. Federated learning is an effective method to share ML models without jeopardizing patient privacy. It is invaluable in the context of COVID-19, where limited data are segregated across various institutions. We demonstrated that federated learning models outperformed locally trained models to predict mortality. Federated learning offers a promising opportunity to construct more robust predictive models that can be leveraged in this pandemic. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted August 14, 2020. . https://doi.org/10.1101/2020.08.11.20172809 doi: medRxiv preprint infrastructure to investigate COVID-19. Journal of the American Medical Informatics Association 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted August 14, 2020. . https://doi.org/10.1101/2020.08.11.20172809 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted August 14, 2020. . https://doi.org/10.1101/2020.08.11.20172809 doi: medRxiv preprint cross validation are shown. Average performance of each model across all five sites is presented in (F). . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted August 14, 2020. . https://doi.org/10.1101/2020.08.11.20172809 doi: medRxiv preprint An interactive web-based dashboard to track COVID-19 in real time Sampling the host response to SARS-CoV-2 in hospitals under siege COVID-19 and Cardiovascular Disease Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Chinese Center for Disease Control and Prevention The Incubation Period of Coronavirus Disease From Publicly Reported Confirmed Cases: Estimation and Application CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV) Pathological findings of COVID-19 associated with acute respiratory distress syndrome Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19 Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection Covid-19 and People with HIV Infection: Outcomes for Hospitalized Patients Artificial intelligence-enabled rapid diagnosis of patients with COVID-19 NCATS. National COVID Cohort Collaborative (N3C). 2020 International Electronic Health Record-Derived COVID-19 Clinical Course Profiles: The 4CE Consortium Federated learning for healthcare informatics Blockchain-Federated-Learning and Deep Learning Models for COVID-19 detection using CT Imaging A collaborative online AI engine for CT-based COVID-19 diagnosis SCOR: A secure international informatics We thank the Clinical Data Science and Mount Sinai Data Warehouse teams for providing data.We appreciate all the nurses, physicians, and providers who contributed to the care of these patients. This work is for patients and their family members who were affected by this pandemic.